Clinical Trial Update: Comparison Study of PF530 and Betaferon in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study comparing PF530 and Betaferon in healthy subjects has completed, assessing pharmacokinetics and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)
• PF530

Snippet

Sponsor: Pfenex, Inc | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED